{"disease":{"id":"lateral-canthal-lines-lcl","name":"lateral canthal lines lcl"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04247074","title":"Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":413,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04985916","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-210","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":false},{"nct_id":"NCT07492277","title":"A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Croma-Pharma GmbH","has_results":false},{"nct_id":"NCT03912805","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-209","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}